Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China
· Delayed Price · Currency is CNY 19.21
+0.61 (3.28%)
Apr 29, 2026, 3:00 PM CST
SHA:600079 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 30,359 | 29,560 | 37,611 | 39,995 | 38,443 | 36,247 | Upgrade
|
| Market Cap Growth | -8.39% | -21.41% | -5.96% | 4.04% | 6.06% | -30.05% | Upgrade
|
| Enterprise Value | 37,063 | 36,756 | 45,503 | 47,619 | 46,493 | 46,087 | Upgrade
|
| Last Close Price | 18.60 | 18.11 | 23.03 | 23.68 | 22.62 | 21.15 | Upgrade
|
| PE Ratio | 16.32 | 15.93 | 28.28 | 18.74 | 15.48 | 27.52 | Upgrade
|
| Forward PE | 12.74 | 16.68 | 16.68 | 16.68 | 16.68 | 16.68 | Upgrade
|
| PS Ratio | 1.27 | 1.23 | 1.48 | 1.63 | 1.72 | 1.76 | Upgrade
|
| PB Ratio | 1.38 | 1.34 | 1.82 | 1.99 | 2.14 | 2.32 | Upgrade
|
| P/TBV Ratio | 1.83 | 1.79 | 2.52 | 2.82 | 3.17 | 3.58 | Upgrade
|
| P/FCF Ratio | 17.00 | 16.55 | 32.90 | 4478.82 | - | 76.18 | Upgrade
|
| P/OCF Ratio | 12.05 | 11.74 | 17.38 | 20.33 | 15.75 | 16.64 | Upgrade
|
| PEG Ratio | 0.41 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | Upgrade
|
| EV/Sales Ratio | 1.55 | 1.53 | 1.79 | 1.94 | 2.08 | 2.24 | Upgrade
|
| EV/EBITDA Ratio | 8.09 | 8.07 | 11.33 | 11.59 | 13.79 | 15.26 | Upgrade
|
| EV/EBIT Ratio | 10.38 | 10.29 | 15.10 | 14.35 | 17.55 | 19.52 | Upgrade
|
| EV/FCF Ratio | 20.75 | 20.58 | 39.80 | 5332.50 | - | 96.87 | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.40 | 0.45 | 0.47 | 0.57 | 0.83 | Upgrade
|
| Debt / EBITDA Ratio | 1.91 | 1.91 | 2.30 | 2.28 | 3.02 | 4.27 | Upgrade
|
| Debt / FCF Ratio | 4.89 | 4.89 | 8.11 | 1052.70 | - | 27.30 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.16 | 0.21 | 0.22 | 0.23 | 0.44 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.79 | 0.79 | 1.08 | 1.06 | 1.22 | 2.28 | Upgrade
|
| Net Debt / FCF Ratio | 2.02 | 2.02 | 3.78 | 487.22 | -6.13 | 14.47 | Upgrade
|
| Asset Turnover | 0.65 | 0.65 | 0.70 | 0.68 | 0.63 | 0.61 | Upgrade
|
| Inventory Turnover | 3.60 | 3.60 | 3.93 | 3.78 | 3.86 | 4.07 | Upgrade
|
| Quick Ratio | 1.49 | 1.49 | 1.17 | 1.14 | 0.98 | 0.91 | Upgrade
|
| Current Ratio | 1.83 | 1.83 | 1.49 | 1.49 | 1.28 | 1.17 | Upgrade
|
| Return on Equity (ROE) | 11.67% | 11.67% | 8.72% | 14.80% | 18.29% | 12.70% | Upgrade
|
| Return on Assets (ROA) | 6.09% | 6.09% | 5.18% | 5.75% | 4.63% | 4.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.26% | 11.51% | 8.94% | 11.88% | 10.65% | 9.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.00% | 14.00% | 13.00% | 14.40% | 12.70% | 11.90% | Upgrade
|
| Earnings Yield | 6.11% | 6.28% | 3.54% | 5.34% | 6.46% | 3.63% | Upgrade
|
| FCF Yield | 5.88% | 6.04% | 3.04% | 0.02% | -1.75% | 1.31% | Upgrade
|
| Dividend Yield | 2.58% | 2.65% | 2.04% | 1.94% | 0.71% | 0.71% | Upgrade
|
| Payout Ratio | 56.90% | 56.90% | 95.45% | 27.53% | 24.67% | 50.53% | Upgrade
|
| Buyback Yield / Dilution | -0.36% | -0.36% | 0.47% | -1.01% | -0.42% | -16.59% | Upgrade
|
| Total Shareholder Return | 2.22% | 2.29% | 2.52% | 0.93% | 0.29% | -15.88% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.